doi:10.16139/j.1007-9610.2019.05.006

[1] Early Breast Cancer Trialists' Collaborative Group
(EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet,2011,378(9804):1707-1716.
[2] START Trialists' Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial[J]. Lancet Oncol,2008,9(4):331-341.
[3] Whelan TJ, Pignol JP, Levine MN, et al.Long-term results of hypofractionated radiation therapy for breast cancer[J]. N Engl J Med,2010,362(6):513-520.
[4] Smith BD, Bentzen SM, Correa CR, et al.Fractionation for whole breast irradiation: an American Society for Radiation Oncology(ASTRO) Evidence-Based Guideline[J]. Int J Radiat Oncol Biol Phys.2011,81(1):59-68.
[5] Haviland JS, Owen JR, Dewar JA, et al.The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials[J]. Lancet Oncol,2013,14(11):1086-1094.
[6] Smith BD, Bellon JR, Blitzblau R, et al.Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology(ASTRO) evidence-based guideline[J]. Pract Radiat Oncol,2018,8(3):145-152.
[7] Strnad V, Ott OJ, Hildebrandt G, et al.5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial[J]. Lancet,2016,387(10015):229-238.
[8] Correa C, Harris EE, Leonardi MC, et al.Accelerated partial breast irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement[J]. Pract Radiat Oncol,2017,7(2):73-79.
[9] EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials[J]. Lancet,2014,383(9935):2127-2135.
[10] Poortmans PM, Collette S, Kirkove C, et al.Internal mammary and medial supraclavicular irradiation in breast cancer[J]. N Engl J Med,2015,373(4):317-327.
[11] Whelan TJ, Olivotto IA, Parulekar WR, et al.Regional nodal irradiation in early-stage breast cancer[J]. N Engl J Med,2015,373(4):307-316.
[12] Thorsen LB, Offersen BV, Danø H, et al.DBCG-IMN: A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J]. J Clin Oncol,2016,34(4):314-320.
[13] Wang SL, Fang H, Song YW, et al.Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial[J]. Lancet Oncol,2019,20(3):352-360.
[14] NCCN. Clinical Practice Guidelines in Oncology-Breast Cancer(2016 Version 1)[DB/OL]. 2015-11-18[2019-09-11].http://www.nccn.org.
[15] Hughes KS, Schnaper LA, Bellon JR, et al.Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343[J]. J Clin Oncol,2013,31(19):2382-2387.
[16] Kunkler IH, Williams LJ, Jack WJL, et al.Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial[J]. Lancet Oncol,2015,16(3):266-273.
[17] Solin LJ, Gray R, Hughes LL, et al.Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 Study[J]. J Clin Oncol,2015,33(33):3938-3944.
[18] Panchal H, Matros E.Current trends in postmastectomy breast reconstruction[J]. Plast Reconstr Surg,2017,140(5S Advances in Breast Reconstruction): 7S-13S.
[19] 修秉虬, 郭瑢, 杨犇龙, 等. 中国乳腺癌术后乳房重建手术横断面调查研究[J]. 中华肿瘤杂志,2019,41(7): 546-551.
[20] Jagsi R, Momoh AO, Qi J, et al.Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction[J]. J Natl Cancer Inst,2018,110(2). doi: 10.1093/jnci/djx148.
[21] Vargo JA, Beriwal S.RTOG Chest Wall Contouring Guidelines for post-mastectomy radiation therapy: Is it evidence-based?[J]. Int J Radiat Oncol Biol Phys,2015,93(2):266-267.
[22] Offersen BV, Boersma LJ, Kirkove C, et al.ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer[J]. Radiother Oncol,2015,114(1):3-10.
[23] Nissen HD, Yates ES, Andersen K, et al.PO-0918: Consensus on target volume delineation and treatment planning strategy for the DBCG RT Recon trial[J]. Radiother Oncol,2018,127:S492-S494.
[24] Kaidar-Person O, Vrou Offersen B, Hol S, et al.ESTRO ACROP consensus guideline for target volume delinea-tion in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer[J]. Radiother Oncol,2019,137:159-166.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386.
[2]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391.
[3]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395.
[4]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402.
[5]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405.
[6]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420.
[9]	YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428.
[10]	PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467.
[11]	ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472.
[12]	WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477.
[13]	LIU Miao, SHEN Yan, FU Xiaohong, HU Jiaojiao, CHEN Qingqing, YING Tao. A comparative study on breast cancer between smaller and larger diameters using conventional ultrasound and contrast-enhanced ultrasound [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 229-233.
[14]	CHEN Yuanyuan, YE Xin, TANG Yongzhe, WANG Jie, HE Qi. Prognosis of invasive micropapillary carcinoma versus invasive ductal carcinoma of the breast: a comparative analysis after propensity score matching [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 353-360.
[15]	CHEN Xiaosong, LI Shuai, WU Jiayi, HUANG Ou, CHAI Weimin, YAO Jiejie, ZHU Ying, XU Chen, CHEN Jiayi, QU Qing, FEI Xiaochun, DING Xiaoyi, LIN Lin, ZHANG Nan, FANG Qiong, HE Jianrong, ZHU Li, LI Yafen, CHEN Weiguo, SHEN Kunwei. Diagnosis, treatment and survival of breast cancer patients in single large hospital: a 10-year analysis [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 149-158.